Cantor Fitzgerald Reaffirms “Overweight” Rating for Elevance Health (NYSE:ELV)

Cantor Fitzgerald reissued their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research note released on Friday morning, Benzinga reports. They currently have a $547.00 target price on the stock. Other research analysts have also recently issued research reports about the stock. Morgan Stanley boosted their price target on shares […]

Leave a Reply

Your email address will not be published.

Previous post Genius Sports’ (GENI) “Buy” Rating Reiterated at Needham & Company LLC
Next post New Chicago Cubs pitcher Shōta Imanaga, aka ‘The Throwing Philosopher,’ isn’t satisfied despite his success in Japan